article says " SRPT is NOW One Of The Major Players. LINK
Seeking Alpha " Muscular Dystrophy Drug Succeeds, Sarepta Buyers Flood In"
4/11/13 By: Brian L Wilson
Sarepta is now one of the major players in the field, which is one of the reasons it has received so muchattention this year. Although valuable by itself, eteplirsen is also a financial stepping stone that Sarepta will use to leverage its RNA technology in other indications